Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain. 2004

Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
Department of Veterinary Basic Sciences, The Royal Veterinary College, London, United Kingdom.

BACKGROUND In vivo, bones' osteogenic response to mechanical loading involves proliferation of surface osteoblasts. This response is replicated in vitro and involves ERK-mediated activation of the estrogen receptor (ER) alpha and upregulation of estrogen response element activity. This proliferative response can be blocked by selective estrogen receptor modulators and increased by transfection of additional ERalpha. METHODS We have now investigated the mechanisms of ER involvement in osteoblast-like cells' early responses to strain by comparing the responses of primary cultures of these cells derived from homozygous ERalpha knockout (ERKO) mice (ERalpha-/-) with those from their wildtype (ERalpha+/+) and heterozygous (ERalpha+/-) littermates and from ER/beta knockout (BERKO) mice (ERbeta+/+, ERbeta+/-, and ERbeta-/-). RESULTS Whereas ERalpha+/+, ERalpha+/-, ERbeta+/+, and ERbeta-/- cells proliferate in response to a single 10-minute period of cyclic strain, ERalpha-/- cells do not. Transfection of fully functional, but not mutant, ERalpha rescues the proliferative response to strain in these cells. The strain-related response of ERalpha-/- cells is also deficient in that they show no increased activity of an AP-I driven reporter vector and no strain-related increases in NO production. Their strain-related increase in prostacyclin production is retained. They proliferate in response to fibroblast growth factor-2 but not insulin-like growth factor (IGF)-I or IGF-II, showing the importance of ERalpha in the IGF axis and the ability of ERalpha-/- cells to proliferate normally in response to a mitogenic stimulus that does not require functional ERalpha. CONCLUSIONS These data indicate ERalpha's obligatory involvement in a number of early responses to mechanical strain in osteoblast-like cells, including those that result in proliferation. They support the hypothesis that reduction in ERalpha expression or activity after estrogen withdrawal results in a less osteogenic response to loading. This could be important in the etiology of postmenopausal osteoporosis.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
June 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
November 1997, Proceedings of the National Academy of Sciences of the United States of America,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
March 2000, Stroke,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
May 2003, Neuroendocrinology,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
June 1999, Endocrinology,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
March 1991, Biomaterials,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
August 2009, Endocrinology,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
January 2007, American journal of respiratory and critical care medicine,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
September 2004, Steroids,
Helen L Jessop, and Rosemary F L Suswillo, and Simon C F Rawlinson, and Gul Zaman, and Karla Lee, and Vicky Das-Gupta, and Andrew A Pitsillides, and Lance E Lanyon
January 2016, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!